Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
Abstract Background Cancer‐associated fibroblasts (CAFs) play an important role in the
induction of chemo‐resistance. This study aimed to clarify the mechanism underlying CAF …
induction of chemo‐resistance. This study aimed to clarify the mechanism underlying CAF …
Selective internal radiation therapy of metastatic breast cancer to the liver: A meta-analysis
C Liu, G Tadros, Q Smith, L Martinez, J Jeffries… - Frontiers in …, 2022 - frontiersin.org
Introduction The aim of this study is to conduct a meta-analysis to assess the efficacy of
yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer …
yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer …
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular …
S Kim, KH Kim, BK Kim, JY Park, SH Ahn… - Journal of …, 2021 - Wiley Online Library
Abstract Background and Aims Recently, lenvatinib demonstrated non‐inferiority to
sorafenib in terms of overall survival (OS) in a randomized phase III study that was …
sorafenib in terms of overall survival (OS) in a randomized phase III study that was …
Immune checkpoint inhibitor‑associated diabetes mellitus in patients with HCC: Report of three cases and literature review
G Wang, J Wang, S Dong… - Experimental and …, 2024 - spandidos-publications.com
Abstract Treatment with immune checkpoint inhibitors (ICIs) is steadily becoming the
standard of care for hepatocellular carcinoma (HCC), with an increasing number of immune …
standard of care for hepatocellular carcinoma (HCC), with an increasing number of immune …
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Purpose To compare the treatment response and progression-free survival (PFS) in
advanced hepatocellular carcinoma (HCC) patients who received sorafenib treatment either …
advanced hepatocellular carcinoma (HCC) patients who received sorafenib treatment either …
Efficacy of yttrium-90 transarterial radioembolisation in advanced hepatocellular carcinoma: an Experience with Hybrid angio-computed Tomography and glass …
A Baloji, N Kalra, S Chaluvashetty, H Bhujade… - Journal of Clinical and …, 2024 - Elsevier
Background Hepatocellular carcinoma is one of the most common malignancies worldwide.
Transarterial radioembolisation (TARE) involves selective intra-arterial administration of …
Transarterial radioembolisation (TARE) involves selective intra-arterial administration of …
Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology
Background and aims Transarterial 90Y radioembolization (TARE) is increasingly being
used for hepatocellular carcinoma (HCC) treatment. However, tumor response assessment …
used for hepatocellular carcinoma (HCC) treatment. However, tumor response assessment …
[HTML][HTML] Safety and efficacy of CT-guided iodine-125 brachytherapy for portal vein tumor thrombus in hepatocellular carcinoma
Z Qiu, C Yu, X Qiu, Q Li, J Li, Z Chen, S Chang… - Academic …, 2023 - Elsevier
Rationale and objectives Portal vein tumor thrombus (PVTT) seriously reduces the survival
of patients with hepatocellular carcinoma (HCC). CT-guided iodine-125 (125 I) …
of patients with hepatocellular carcinoma (HCC). CT-guided iodine-125 (125 I) …
Noninvasive imaging evaluation based on computed tomography of the efficacy of initial transarterial chemoembolization to predict outcome in patients with …
Y Dai, H Jiang, ST Feng, Y Xia, J Li… - Journal of …, 2022 - Taylor & Francis
Purpose This study aims to develop a new model to more comprehensively and accurately
predict the survival of patients with HCC after initial TACE. Patients and Methods The whole …
predict the survival of patients with HCC after initial TACE. Patients and Methods The whole …
Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma
B Kim, SS Kim, SW Cho, JY Cheong, J Huh, JK Kim… - European …, 2021 - Springer
Objective We investigated whether liver stiffness (LS) quantified using magnetic resonance
elastography (MRE) could predict the prognosis of advanced hepatocellular carcinoma …
elastography (MRE) could predict the prognosis of advanced hepatocellular carcinoma …